The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury ...

Prostate Treatment Market has seen significant attention due to the increasing prevalence of prostate-related conditions, particularly among the aging male population. Benign prostatic hyperplasia, a ...

Kenya: Duale Calls for Stronger Governance in National Referral Hospitals during Kenyatta National Hospital Visit ...

Boston)—In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without additional systemic ...

During his visit, Hon. Duale praised KNH for its decades of leadership in providing specialized medical services, noting the ...

The Digestive Endoscopy Unit at Kuwait Hospital in Sharjah achieved significant milestones during the first quarter of 2025 ...

Allison Wise, associate editor for Shop TODAY, shares the painful journey that led to her endometriosis diagnosis after ...

May 12, 2025UroGen Pharma Ltd. misses on earnings expectations. Reported EPS is $-0.92 EPS, expectations were $-0.83. Operator: Hello and welcome to UroGen Pharma First Quarter 2025 Earnings ...

If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for ...

Quirónsalud Torrevieja Hospital hosted over 100 medical experts from across the Valencian Community to explore the latest ...

The FDA has granted a third approval for WELIREG, authorizing its use as a treatment for patients with rare endocrine system tumors known as ...

Biodexa Pharmaceuticals PLC Shareholder Update Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of ...